# Gemcitabine in NK/T Cell Lymphoma

> **NCT01660568** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 20 (actual)

## Conditions studied

- NK/T Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01660568
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01660568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01660568, "Gemcitabine in NK/T Cell Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01660568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*